These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 12090541

  • 1. Interferon-alpha. Amarillo Biosciences.
    Barnard DL.
    Curr Opin Investig Drugs; 2002 May; 3(5):693-7. PubMed ID: 12090541
    [Abstract] [Full Text] [Related]

  • 2. [Interferon alpha (IFNalpha) treatment for Sjögren's syndrome].
    Shiozawa K, Shiozawa S.
    Nihon Rinsho; 2006 Jul; 64(7):1345-53. PubMed ID: 16838655
    [Abstract] [Full Text] [Related]

  • 3. Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.
    Li D, Xu DZ, Choi BC, Men K, Zhang JX, Lei XY, Yan YP.
    J Med Virol; 2005 Jun; 76(2):203-7. PubMed ID: 15834875
    [Abstract] [Full Text] [Related]

  • 4. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC.
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [Abstract] [Full Text] [Related]

  • 5. The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host.
    Braun M, Vierling JM.
    Liver Transpl; 2003 Nov; 9(11):S79-89. PubMed ID: 14586901
    [Abstract] [Full Text] [Related]

  • 6. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
    Hauser P.
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
    [Abstract] [Full Text] [Related]

  • 7. Current state of interferon therapy in the treatment of chronic hepatitis B.
    Manns MP.
    Semin Liver Dis; 2002 Mar; 22 Suppl 1():7-13. PubMed ID: 12447724
    [Abstract] [Full Text] [Related]

  • 8. Drug evaluation: Albuferon-alpha--an antiviral interferon-alpha/albumin fusion protein.
    Chemmanur AT, Wu GY.
    Curr Opin Investig Drugs; 2006 Aug; 7(8):750-8. PubMed ID: 16955687
    [Abstract] [Full Text] [Related]

  • 9. Interferon alpha and its contribution to autoimmunity.
    Selmi C, Lleo A, Zuin M, Podda M, Rossaro L, Gershwin ME.
    Curr Opin Investig Drugs; 2006 May; 7(5):451-6. PubMed ID: 16729722
    [Abstract] [Full Text] [Related]

  • 10. Interferon alpha delivery systems for the treatment of hepatitis C.
    Thitinan S, McConville JT.
    Int J Pharm; 2009 Mar 18; 369(1-2):121-35. PubMed ID: 19103271
    [Abstract] [Full Text] [Related]

  • 11. [Depressive disorders and interferon alpha].
    Hardy P.
    Gastroenterol Clin Biol; 1996 Mar 18; 20(3):255-7. PubMed ID: 8763063
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H, Enomoto H, Kishima Y, Yamamoto M, Yoshida K, Okuda Y, Hirotani T, Kuroda T, Ito H, Matsuda M, Terabayashi M, Noguchi S, Kawase I, Nakamura H.
    Hepatogastroenterology; 2003 Mar 18; 50(54):2112-6. PubMed ID: 14696476
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
    McHutchison JG, Shiffman ML, Cheung RC, Gordon SC, Wright TL, Pottage JC, McNair L, Ette E, Moseley S, Alam J.
    Antivir Ther; 2005 Mar 18; 10(5):635-43. PubMed ID: 16152757
    [Abstract] [Full Text] [Related]

  • 16. Guillain-Barré syndrome during treatment with interferon alpha for hepatitis B.
    Boz C, Ozmenoglu M, Aktoz G, Velioglu S, Alioglu Z.
    J Clin Neurosci; 2004 Jun 18; 11(5):523-5. PubMed ID: 15177399
    [Abstract] [Full Text] [Related]

  • 17. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients.
    Fagiuoli S, Pevere S, Minniti F, Livi U, Caforio AL, Naccarato R, Chiaramonte M.
    Transplantation; 2003 Apr 15; 75(7):982-6. PubMed ID: 12698084
    [Abstract] [Full Text] [Related]

  • 18. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R, Planas Vilà R, Durández Lazaro R, Fábregas Puigtió S.
    Gastroenterol Hepatol; 2002 Oct 15; 25(8):483-6. PubMed ID: 12361528
    [Abstract] [Full Text] [Related]

  • 19. Impact of interferon-alpha therapy on the serum level of alpha-fetoprotein in patients with chronic viral hepatitis.
    Kasztelan-Szczerbińska B, Słomka M, Celiński K, Szczerbiński M.
    Rocz Akad Med Bialymst; 2003 Oct 15; 48():74-7. PubMed ID: 14737946
    [Abstract] [Full Text] [Related]

  • 20. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO, Schuchmann M, Link R, Hillenbrand H, Rahman F, Sprinzl M, Mudter J, Löhr HF, Galle PR.
    Liver Int; 2006 Apr 15; 26(3):319-25. PubMed ID: 16584394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.